Teva Pharmaceutical Industries Ltd. ADR 0.52% $23.98B ...

The FDA has started a review of GSK’s five-in-one meningococcal vaccine, cueing up a decision in mid-February next year, as it tries to chase down a rival candidate from Pfizer cleared last year.

The major U.S. index futures are currently pointing to a lower open on Friday, with stocks likely to move to the downside after ...

GlaxoSmithKline PLC creates, discovers, develops, manufactures and markets pharmaceutical products including respiratory and antiviral, vaccines, over-the-counter (OTC) medicines and health-related ...